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Alzheimer’s disease (AD) is the most common neurodegenerative disorder and is char-
acterized by a progressive decline of cognitive functions. The neuropathological features 
of AD include amyloid beta (Aβ) deposition, intracellular neurofibrillary tangles derived 
from the cytoskeletal hyperphosphorylated tau protein, amyloid angiopathy, the loss of 
synapses, and neuronal degeneration. In the last decade, inflammation has emerged as a 
key feature of AD, but most studies have focused on the role of microglia-driven neuroin-
flammation mechanisms. A dysfunctional blood–brain barrier has also been implicated in 
the pathogenesis of AD, and several studies have demonstrated that the vascular depo-
sition of Aβ induces the expression of adhesion molecules and alters the expression of 
tight junction proteins, potentially facilitating the transmigration of circulating leukocytes. 
Two-photon laser scanning microscopy (TPLSM) has become an indispensable tool to 
dissect the molecular mechanisms controlling leukocyte trafficking in the central nervous 
system (CNS). Recent TPLSM studies have shown that vascular deposition of Aβ in the 
CNS promotes intraluminal neutrophil adhesion and crawling on the brain endothelium 
and also that neutrophils extravasate in the parenchyma preferentially in areas with Aβ 
deposits. These studies have also highlighted a role for LFA-1 integrin in neutrophil accu-
mulation in the CNS of AD-like disease models, revealing that LFA-1 inhibition reduces 
the corresponding cognitive deficit and AD neuropathology. In this article, we consider 
how current imaging techniques can help to unravel new inflammation mechanisms in 
the pathogenesis of AD and identify novel therapeutic strategies to treat the disease by 
interfering with leukocyte trafficking mechanisms.
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iNTRODUCTiON
Alzheimer’s disease (AD) is the most common neurodegenerative cause of dementia in the elderly 
and is characterized by a progressive deterioration of cognitive functions. The neuropathological 
features include amyloid beta (Aβ) neuritic plaques, neurofibrillary tangles (NFTs) comprising 
aggregates of hyperphosphorylated microtubule tau protein, amyloid angiopathy, and the loss of 
neurons and synapses (1). The major pathogenic concept in the field of AD research is the amyloid 
cascade hypothesis, which states that the sequence of pathological events leading to AD is character-
ized by the accumulation of Aβ peptides resulting from the aberrant processing of amyloid precursor 
protein (APP) and dysfunctional Aβ clearance, followed by the deposition of NFTs and the onset of 
synaptic dysfunction and neuronal loss. Aβ peptides are formed by the proteolytic cleavage of APP 
due to the sequential activities of β-site APP-cleaving enzyme 1 (BACE-1) (β-secretase), γ-secretase, 
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and a protein complex with presenilin 1 (PS1) at its catalytic core. 
Although amyloid plaques and aggregated tau are both part of 
the neuropathological definition of the disease, numerous stud-
ies suggest that soluble oligomeric forms of Aβ and tau are the 
predominant mediators of cytotoxicity in AD (2).
Alzheimer’s disease pathology is also characterized by an 
inflammatory response primarily driven by cytokines and the 
intrinsic myeloid cells in the brain, which are known as microglia 
(3). It is now widely accepted that microglia-mediated neuro-
inflammatory responses may promote the neurodegeneration 
observed in AD (1, 3). Microglial activation precedes neuropil 
loss in AD patients, and recent genome-wide association stud-
ies have revealed that microglial genes, such as CD33, TREM2, 
and HLA-DR, are associated with susceptibility to the late-onset 
form of the disease (3). Furthermore, in response to Aβ or NFTs, 
microglial cells produce proinflammatory cytokines, chemokines, 
and complement peptides, which can recruit leukocyte sub-
populations to the brain. Aβ also stimulates microglia to produce 
reactive nitrogen intermediates, such as nitric oxide (NO) and 
reactive oxygen species (ROS), and the resulting oxidative stress 
induces neuronal damage (3).
Circulating leukocytes may also play a role in the inflam-
mation process during AD. The migration of leukocytes from 
blood vessels into the central nervous system (CNS) involves a 
sequence of adhesion and activation events including (1) capture 
(tethering) and rolling, which are mediated by the interactions 
between selectins and mucins, and/or between integrins and 
proteins with immunoglobulin domains; (2) activation induced 
by chemokines, resulting in the subsequent activation of integ-
rins; (3) arrest mediated by integrins and their counter-ligands; 
and (4) diapedesis or transmigration (4). Additional steps may 
include slow rolling, adhesion strengthening and spreading, and 
intravascular crawling (5). Leukocyte trafficking in the CNS 
during inflammatory diseases is mediated predominantly by 
endothelial E-selectin, P-selectin, and their mucin ligands, as well 
as leukocyte integrins including α4β1 (also known as very late 
antigen 4, VLA-4) and αLβ2 (also known as leukocyte function-
associated antigen 1, LFA-1), which bind the endothelial vascular 
cell adhesion molecule (VCAM-1) and intercellular cell adhesion 
molecule (ICAM-1), respectively.
The role of circulating immune system cells in AD-related 
brain damage is poorly understood, but the use of in vivo imag-
ing techniques, such as two-photon laser scanning microscopy 
(TPLSM), can provide insights into the mechanisms controlling 
leukocyte trafficking in AD and may lead to the development 
of novel therapeutic strategies to delay the progression of the 
disease. In this review, we discuss recent work on the role of cir-
culating leukocytes in AD, highlighting the use of in vivo imaging 
to investigate leukocyte recruitment in the CNS and to study the 
basis of novel disease mechanisms.
LeUKOCYTe TRAFFiCKiNG iN AD
Monocytes are circulating leukocytes that play an important role 
in the innate immune response against pathogens. Numerous 
studies have shown that peripheral myeloid cells can infiltrate 
brain tissue and reduce the deposition of Aβ plaques (6–9). 
The entry of monocytes into the CNS is tightly regulated and 
involves the CC-chemokine ligand 2 (CCL2)–CCR2 axis (10). 
Aβ is chemotactic for monocytes, and it induces the secretion 
of proinflammatory cytokines and monocyte transendothelial 
migration in a blood–brain barrier (BBB) model, in a process 
that involves the Aβ receptor (RAGE) and platelet endothelial 
cell adhesion molecule (PECAM-1) expressed on endothelial 
cells (11, 12). In agreement with these in vitro studies, the injec-
tion of synthetic Aβ peptides into the hippocampus triggers 
the trafficking of bone-marrow-derived monocytic cells into 
the brain, which then differentiate into ramified microglia and 
penetrate into the core of Aβ plaques (7, 13). Furthermore, recent 
data indicate that infiltrating monocytes rather than resident 
microglia express TREM2, a receptor involved in myeloid cell 
phagocytosis, further supporting the role of peripheral myeloid 
cells in AD pathogenesis (14). Intravital TPLSM has elegantly 
confirmed that patrolling monocytes are attracted to and crawl 
onto the luminal walls of Aβ-positive veins but not Aβ-positive 
arteries or Aβ-negative blood vessels (15).
Neutrophils are the most abundant population of cells in 
the blood and are the primary mediators of the innate immune 
response. Previous reports (16, 17), including our own results 
(18), have shown that neutrophils do not necessarily need to 
accumulate in tissues in high numbers in order to induce tissue 
damage: intravascular adhesion per se without transmigration is 
sufficient to induce endothelial injury. The role of neutrophils in 
the induction of neuropathological changes and memory deficit 
in AD models has been demonstrated only recently (19). A higher 
number of infiltrating neutrophils was observed at the onset of 
cognitive deficits in 5xFAD and 3xTg-AD mice, especially in 
the cortex and hippocampus. In corresponding TPLSM studies, 
neutrophil extravasation was observed at the early stage of the 
disease inside the cerebral parenchyma, particularly in areas 
adjacent to vascular Aβ deposits or rich in intraparenchymal Aβ 
plaques (19). Similarly, Gr1+-labeled cells also infiltrate the brain 
parenchyma of 5xFAD mice and migrate toward Aβ plaques (20). 
These data, together with previous in vitro results, suggest that Aβ 
plays a role in the chemotaxis and accumulation of neutrophils in 
the brains of AD mice (21, 22). Furthermore, soluble Aβ oligom-
ers rapidly trigger neutrophil adhesion to integrin ligands in vitro 
and induce the transition of LFA-1 integrin from the low- to the 
high-affinity binding state, suggesting that Aβ plays a key role in 
neutrophil intravascular adhesion and migration into the brain 
during AD (19). Neutrophils migrate into the brains of mice with 
AD-like disease by using LFA-1 integrin, which controls both 
intravascular adhesion and intraparenchymal motility. Indeed, 
the treatment of AD-like transgenic mice with monoclonal 
antibodies that block LFA-1 integrin or deplete neutrophils at 
early stages of the disease (when mice start to present memory 
impairment) mitigated the neuropathological hallmarks of AD 
and reversed the cognitive deficits. Most importantly from a 
therapeutic perspective, blocking neutrophil adhesion during the 
early stages of the disease provided a long-term beneficial effect 
on cognition in older mice (19).
The presence of neutrophils in the brains of AD subjects was 
previously suggested by the presence of cells expressing cathepsin 
G, a protease produced specifically by neutrophils, within the 
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AD brain parenchyma and inside cerebral blood vessels (23). 
Additionally, the presence of CAP37, an inflammatory mediator 
expressed in neutrophils, was reported in the blood vessels and 
hippocampal vasculature of AD patients (24, 25). However, the 
first definitive evidence for the presence of neutrophils in the 
AD brain was our confirmation that myeloperoxidase (MPO)+ 
cells are localized in areas with Aβ deposits (19). These cells were 
typically found around the periphery of Aβ plaques at a distance 
of <50 μm, and their non-random distribution suggested that Aβ 
influences the microenvironmental positioning of neutrophils 
inside the AD brain.
Several reports indicate that T cells also accumulate in the 
AD brain (26–29). For example, a greater number of activated 
CD4+ and CD8+ T cells was observed in the blood, adhering to 
the vascular endothelium or migrating into the parenchyma of 
AD patients, compared to healthy controls or patients with other 
types of dementia (4, 26–29). Notably, the majority of T cells in 
AD brain tissue are located in the hippocampus and other limbic 
structures, which are among those regions most affected in AD 
(28). In support of these data, enhanced activated CD4+ and CD8+ 
were recently identified in the cerebrospinal fluid (CSF) of indi-
viduals with mild cognitive impairment (MCI) and patients with 
mild AD, with the proportion of activated CD8+ T cells showing 
the greatest increase (30). In agreement with human data, mouse 
studies have shown that T cells infiltrate the brains of APP/PS1 
mice, and a proportion of these cells secrete interferon (IFN)-γ 
or interleukin (IL)-17 (31). This suggests that the inflammatory 
response stimulated by T cells that have migrated into the AD 
brain may activate microglia and astrocytes and may recruit other 
inflammatory cells that are potentially harmful to the CNS, thus 
exacerbating the pathogenesis of AD.
Taken together, the studies discussed in this section sug-
gest that a role for circulating leukocytes in AD is becoming 
clearer, but further studies are needed to determine the impact 
of specific immune cell populations on the cognitive deficit and 
neuropathological changes in AD. In this context, future TPLSM 
studies may provide key data to increase our understanding of the 
mechanisms controlling leukocyte trafficking in the AD brain, 
as well as interactions between migrating leukocytes and CNS-
resident cells.
TPLSM – THe GeNeRAL CONTeXT
The optical principles of two-photon microscopy are based on 
the absorption of two longer-wavelength lower-energy photons 
as a single quantum of energy by a fluorophore, thus promot-
ing an electron to an excited state (32). TPLSM offers several 
advantages over traditional forms of microscopy for the inves-
tigation of living systems because it provides three-dimensional 
deep-tissue images and single-cell spatiotemporal information 
that other imaging techniques cannot achieve (33–35). TPLSM 
is particularly suitable for high-resolution imaging in intact thick 
tissues, such as whole organs, brain slices, embryos, and live 
animals (intravital imaging). Extensive tissue penetration is pos-
sible due to the reduced scattering of the infrared (IR) excitation 
light compared to one-photon confocal microscopy. The restric-
tion of two-photon excitation solely to the focal plane provides 
most of the advantages over traditional confocal microscopy. 
TPLSM generates fluorescence only within the focal plane, thus 
substantially reducing photobleaching and photodamage outside 
the excitation volume (which represents only a small proportion 
of the overall sample), and thereby prolonging the viability of 
specimens especially during long-term imaging.
The spatiotemporal dynamics of leukocyte trafficking can be 
investigated in vivo using cutting-edge TPLSM technology (36, 
37). This technique has changed our static view of the immune 
system and allowed the dissection of leukocyte migration behav-
ior and cell–cell contacts, which are fundamental requirements 
for an effective immune response (38, 39). Several aspects of 
leukocyte migration that could not be predicted using in  vitro 
systems have been identified, thanks to this advanced technology, 
including leukocyte intravascular crawling and the directional 
movement and polarization of emigrated leukocytes along an 
extravascular chemokine gradient (40, 41).
TPLSM iN THe AD BRAiN
Two-photon laser scanning microscopy has recently contributed 
to several developments in the field of neuroscience, facilitat-
ing studies of cell morphology and function in the living brain. 
TPLSM has become increasingly necessary to study structural and 
functional changes in the living brain because the imaging of neu-
rons, glia, and vasculature provides new insights into the function 
of the CNS under physiological and pathophysiological conditions 
(42–45). Initial studies investigated the structural plasticity of 
dendritic spines and the axons of pyramidal neurons in the mouse 
cortex and how their changes could influence long-term informa-
tion storage (46, 47). TPLSM also revealed the dynamic structure 
of microglial cells that constantly survey the brain parenchyma 
and switch their behavior to an activated state immediately after 
injury (48). In addition to such morphological studies, TPLSM has 
also been used for calcium imaging, thus improving the analysis of 
neuronal signaling and plasticity (49, 50).
In the context of AD, intravital imaging in the brain has mainly 
been used to study amyloid plaque deposition, dendritic spine loss, 
and microglial aggregation around Aβ plaques (6, 51–55). TPLSM 
has allowed the repeated visualization of the same amyloid plaques 
labeled with fluorescent dyes to evaluate their growth in transgenic 
mouse models of AD (51, 55, 56). A refined TPLSM method was 
used to define the kinetics of amyloid plaque growth in Tg2576 
mice (57). The simultaneous imaging of amyloid plaques and neu-
rons labeled with viral-expressed green fluorescent protein (GFP) 
in a transgenic mouse model of AD highlighted the detrimental 
effect of Aβ on the neuronal circuitry (58).
Recent TPLSM studies have confirmed that dendritic spine 
loss after newborn amyloid deposits persists in the proximity of 
amyloid plaques in APP/PS1 mice (59). TPLSM imaging has also 
revealed that the depletion of Aβ in the brains of PDAPP-YFP 
transgenic mice treated with anti-Aβ antibodies promotes the 
rapid recovery of existing amyloid-associated neuritic dystrophy 
in vivo, indicating that axonal and dendritic damage is a partially 
reversible phenomenon (60).
The availability of transgenic mice expressing fluorescent 
cells, such as microglia, has provided a more intimate view of the 
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interactions between amyloid plaques, neuronal structures, and 
cells in the brain parenchyma during the progression of AD (61) 
or astrocytes (62). The rapid appearance of new amyloid plaques 
induces progressive changes in neurites, manifesting as dendritic 
and axonal abnormalities, and the activation and recruitment of 
microglia to areas with amyloid plaques (63).
Two-photon laser scanning microscopy has also facilitated 
the characterization of impaired microglial functionality near 
amyloid deposits in AD mice, suggesting a correlation between 
plaque deposition and microglial behavior (64).
Two-photon laser scanning microscopy analysis of leukocyte 
trafficking in the inflamed CNS has focused almost exclusively 
on infections, stroke, and experimental autoimmune encepha-
lomyelitis (EAE) (65–69). However, recent TPLSM studies have 
shown that circulating leukocytes migrate into the brain paren-
chyma of AD mice, revealing previously unknown mechanisms 
of AD pathogenesis and helping to identify new therapeutic 
strategies for AD (19, 20). Our recent TPLSM experiments have 
demonstrated that circulating neutrophils arrest and perform 
intraluminal crawling preferentially inside blood vessels with Aβ 
deposits, supporting a role for Aβ in leukocyte migration into the 
brain (19). Furthermore, we have recently shown using TPLSM 
that neutrophils isolated from LFA-1-deficient mice cannot 
adhere to the brain vessels and therefore extravasate in the brain 
parenchyma, suggesting that LFA-1 integrin is a key mediator of 
neutrophil trafficking in AD and that targeting this adhesion mol-
ecule may have a therapeutic effect. Future studies are necessary 
to better understand the dynamics of immune cell trafficking in 
AD and TPLSM experiments that allow the imaging and analysis 
of leukocyte trafficking in the AD brain are discussed below.
iMAGiNG THe CORTeX iN AD MiCe
In vivo imaging in the cortex of AD mice can be achieved using 
deeply anesthetized animals with the head fixed on a stereotaxic 
device to reduce movement artifacts. Mice in deep anesthesia can-
not maintain their core body temperature at 35–38°C. Heat lamps 
or a heated stage are therefore required to maintain the correct 
temperature because leukocyte motility is temperature depend-
ent (70). An incision is made along the midline of the scalp to 
expose the skull, and any fascia overlying the skull is scraped away 
(71). Two different surgical preparations can be used for intravital 
TPLSM in the mouse cortex: the thinned skull preparation and 
open cranial window. Both these methods have advantages and 
drawbacks depending on the purpose of the investigation.
The thinned skull technique involves thinning the calvarium 
to approximately 20–30 μm leaving an intact and almost trans-
parent periosteal layer. A circular region of 1–2 mm in diameter 
is prepared with a high-speed micro drill and/or a stainless steel 
burr above the somatosensory and motor cortex. Heat and 
vibration artifacts are minimized during drilling by the frequent 
application of cold saline solution or artificial CSF. Heating is also 
avoided by interrupting the drilling every few seconds. Bone dust 
is removed using compressed air.
The mouse skull consists of two thin layers of compact bone, 
sandwiching a thick layer of spongy tissue. This spongy bone 
contains tiny cavities arranged in concentric circles and multiple 
canaliculi that carry blood vessels. After removing the external 
compact bone, the middle layer of spongy bone is carefully 
thinned to approximately 75% of its original thickness. Some 
bleeding from the blood vessels running through the canaliculi 
may occur during thinning but usually stops spontaneously (72). 
The clear visualization of the pial vasculature gives an indication 
of the skull thickness, then thinning is continued manually using 
a microsurgical blade. This process is repeated until the bone in 
the central region becomes flexible and maximum image clarity 
is achieved (Figures 1A,B). Once the surgical procedure is com-
plete, the thinned skull preparation can be imaged immediately 
(73). When imaging is completed, the wound margins of the scalp 
are closed using a nylon suture.
Skull thinning creates a translucent viewing window allowing 
the visualization of cells up to a depth of 200–300 μm below the 
pial surface, including the meninges and neocortex but not the 
deeper brain structures (48). Imaging through the thinned cranial 
window is a minimally invasive method allowing long acquisition 
sessions because the thinned skull still protects the brain from 
external changes in temperature and pressure (74, 75). Despite 
minor bleeding from diploic vessels, the thinned skull technique 
leaves the majority of anastomoses between the diploic vessels 
and dural vessels intact. However, thinning the skull to a specific 
depth over a large zone is technically challenging due to the cur-
vature of the skull, and the area should therefore be no more than 
3 mm in diameter to avoid damage to the underlying tissue (72). 
Furthermore, in the case of multiple acquisition sessions over time, 
re-thinning the excess bone deposition after few days is necessary 
to prevent skull regrowth occluding the preparation (73). Among 
the two available techniques, the thinned cranial preparation is 
better for the analysis of larger structures, such as cerebral vascu-
lature, amyloid plaques, and leukocytes (19, 51, 52, 76).
The study of AD mechanisms in mice may benefit from the 
creation of a small break with the tip of a needle in the lateral wall 
at the site of the thinned skull preparation to allow the delivery 
of fluorophores into the brain, leaving the thinned region intact. 
The hole is then filled with sterile bone wax, and the animals are 
allowed to recover on a heating pad before being returned to their 
cages. This approach can be used, e.g., to allow the diffusion of 
anti-Aβ antibodies directly labeled with fluorescein or thioflavin 
S, a sensitive and specific fluorescent reporter for the dense-core 
subset of senile plaques. This molecule has been used to label Aβ 
deposits in transgenic mouse models of amyloid deposition, and 
the growth rate of Aβ plaques and cerebral Aβ angiopathy have 
been extensively monitored in vivo (51, 55, 76–78).
The in vivo imaging of senile plaques in AD mice can also be 
achieved using Methoxy-X04, which can be administered intra-
venously or intraperitoneally (79). Methoxy-X04 is a relatively 
small, lipophilic molecule that can enter the brain rapidly and in 
sufficient amounts to allow the sensitive and specific detection of 
Aβ deposits (79). Senile plaques and cerebrovascular Aβ angiopa-
thy in AD-like mice are visible 30 min after intravenous injection 
or 24 h after intraperitoneal injection (79). The intravenous or 
intraperitoneal administration of Methoxy-X04 is a more physi-
ological approach to label Aβ in vivo compared to the creation of a 
small break in the skull near the thinning region to allow delivery 
of fluorophores into the brain.
FiGURe 1 | Surgical procedures for TPLSM imaging of the brain cortex: thinned skull preparation and open cranial window. (A) For both procedures, a 
circular area of parietal bone is shaved with an electric razor and the scalp is sterilized with alcohol. The head of the anesthetized mouse is then fixed on a 
stereotaxic device to reduce movement artifacts during imaging, and the skull overlying the cortical region is exposed. (B) For the thinned skull preparation, a small 
region on the parietal zone of the skull is thinned using a high-speed micro drill and a stainless steel burr until the cortical vasculature can be seen clearly through the 
thinned skull. The thinned area is enclosed by the black circle. (C) For the open cranial window technique, a small island of cranial bone on the parietal region (black 
circle) is drilled, removed with a pair of sharp forceps, and covered with a circular glass coverslip.
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The second major approach for TSPLM imaging is the open 
cranial window. The most challenging aspect of this technique 
is the surgical skill required for a successful preparation. In this 
procedure, a circular groove is drilled on the parietal region of 
the skull, and the island of cranial bone is carefully removed with 
a pair of sharp forceps. These should be held parallel to the skull 
surface as far as possible to avoid mechanical injury, because the 
dura can be attached to the overlying bone. Immediately after 
removing the region of the skull, slight bleeding above the dura 
may occur from small blood vessels attached to the removed skull 
fragment, but this should stop spontaneously within few seconds. 
The exposed brain tissue is preserved using a drop of 0.9% NaCl. 
A circular glass coverslip (5 mm in diameter) is placed over the 
incision site to cover the window (Figure 1C). After cementing 
the coverslip in place, mice are given a bolus of warm saline 
for rehydration and are allowed to recover from anesthesia for 
7–14 days before imaging. The open cranial window technique 
also makes it unnecessary to introduce a needle-hole in the skull 
to deliver stains and labeling compounds. A recently described 
simple device provides easy physical access to the brain and 
allows long-term imaging (80). After the initial open cranial 
window surgery, a glass coverslip is applied as described above, 
but this has a pre-drilled access hole sealed with biocompatible 
silicone. This device allows many different types of manipulation 
to be carried out for weeks or months, e.g., drug, dye, and virus 
delivery, sample extraction, or electrophysiological recording and 
stimulation, while protecting the brain from infection (80).
The open cranial window provides improved optical access to 
the cortical layers, allowing repeated high-resolution imaging, 
and is preferable for the imaging of small structures, such as 
dendritic spines and filopodia (73, 81). However, removing the 
skull may induce a neuroinflammatory reaction and unavoidable 
meningeal vascular injury, involving the activation of microglia 
and astrocytes in the intact brain (72, 73, 81, 82). In this case, 
only cells lying deeper than 80 μm below the pial surface should 
be considered for image analysis to eliminate possible artifacts 
caused by the surgical preparation.
To conduct multiple imaging sessions, some authors place a 
small metal bar containing a hole for a screw next to the coverslip 
to allow for repositioning of the mouse during subsequent imag-
ing sessions. This approach has been used in Tg2576 mice for the 
long-term in vivo imaging to monitor individual amyloid plaques 
stained with Methoxy-X04 over a period of 6 weeks (55). Other 
studies using the same technique have followed individual Aβ 
plaques in Tg2576 mice for 5 months, confirming the biophysical 
model of Aβ plaque growth in vivo, which had been extrapolated 
from in vitro experiments.
Blood vessels can be labeled by the intravenous injection of 
fluorescent high-molecular-weight dextran (>2000  kDa) or 
semiconductor nanocrystals (quantum dots), which suffer less 
interstitial leakage than dextrans (83) (Figure 2). Leukocytes can 
be labeled ex vivo with vital dyes, such as 7-amino-4-chloromethyl-
coumarin (CMAC, blue), 5- (and 6-) carboxyfluorescein-diacetate 
succinimidyl-ester (CFSE, green), 5- (and 6-) (((4-chloromethyl)
benzoyl)amino)tetramethylrhodamine (CMTMR, orange), 
C42H40ClN3O4 (CMTPX, red), and C33H24N2O9 (SNARF-1, far 
red). The cells can then be adoptively transferred to syngeneic 
recipients allowing tracking for short time periods, usually a few 
days (Figure 2). Alternatively, the use of donor mice expressing 
fluorescent proteins ubiquitously is an option for the in  vivo 
analysis of highly proliferative cell populations (84). Similarly, 
mice expressing fluorescent cell subsets allow the study of specific 
cell populations, such as neutrophils, lymphocytes, microglia, or 
macrophages (61, 85–87). Nowadays, mice engineered for the 
lineage-specific expression of GFP derivatives, such as eCFP and 
eYFP, or dsRed derivatives, such as tdTomato and mCherry, are 
widely used because they are less susceptible to phototoxicity 
and there is no need for cell isolation and labeling. However, 
most of these mice have been generated using GFP derivatives, 
limiting the ability to analyze several reporter genes in the same 
mouse simultaneously. Hence, new IR fluorescent dyes have been 
developed, which also facilitate deeper tissue imaging (88). The 
IR excitation wavelength requires the application of an optical 
parametric oscillator (OPO) to TPLSM. This allows live imaging 
for an extended duration because it reduces the photobleaching 
of fluorophores and phototoxicity-induced tissue damage.
The simultaneous expression of fluorescent proteins or staining 
using fluorescent dyes with different excitation spectra in the same 
FiGURe 2 | Neutrophils invade the brain of 5xFAD mice. Representative TPLSM images of wild-type control mice (A) and 5xFAD mice (B) showing blood 
cortical vessels labeled in green using 525-nm non-targeted Qdots injected before image acquisition and neutrophils labeled in red with the fluorescent cell tracker 
CMTPX. The skull was exposed above the somatosensory cortex using the thinned skull preparation. We performed acquisition inside the brain parenchyma at a 
depth of approximately 150–250 μm. Images were acquired 16–48 h after cell injection. (A) Neutrophils did not interact with the endothelium of blood vessels in 
wild-type control mice. (B) Numerous neutrophils migrated into the brain parenchyma of 5xFAD mice. Scale bars = 50 μm.
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mouse allows the in  vivo visualization of interactions between 
specific cell populations and Aβ deposits, thus enabling the study 
of AD-specific cellular dynamics in the brain. This approach 
was recently used by our group to demonstrate that neutrophils 
migrate inside the parenchyma of 5xFAD–YFPH mice in areas 
with Aβ plaques labeled with Methoxy-X04, probably driven 
by chemotactic factors, potentially including Aβ peptides (19) 
(Figure 3). Our TPLSM studies also showed that the extravasa-
tion of neutrophils inside the brain of 5xFAD–YFPH mice occurs 
in areas depleted for eYFP fluorescent neurons (Figure 3). We 
speculate that eYFP fluorescent neurons are turned off in the 
zones with neutrophil infiltration, probably due to the cytotoxic 
effects of proinflammatory mediators released by neutrophils, 
such as ROS, enzymes, neutrophil extracellular traps (NETs), 
and cytokines. Alternatively, this may reflect an indirect negative 
effect caused by the activation of microglia. Moreover, we have 
shown that neutrophils display arrest and intraluminal crawling 
preferentially inside blood vessels with labeled Aβ deposits and 
that some cells undergo diapedesis adjacent to vascular Aβ depos-
its (19). TPLSM experiments performed by others have shown 
that neutrophils are attracted inside the brain parenchyma by 
chronic Aβ deposition – initially the cells move randomly outside 
the vessels and then they are suddenly and massively recruited to 
specific Aβ plaques in the brain parenchyma (20).
Two-photon laser scanning microscopy can be used to study 
CNS-resident cells (such as neuronal subsets, astrocytes, micro-
glia, and perivascular macrophages) in relation to each other or 
in relation to infiltrating leukocytes. TPLSM studies have shown 
that local resident microglia react to Aβ plaque formation by 
extending processes and subsequently migrating toward plaques 
in APP/PS1 mice crossed with mice containing fluorescent 
microglia (53). Furthermore, astrocytes in the mouse neocortex 
can be visualized in vivo by intravenous injection of the non-toxic 
molecule sulforhodamine B or by using transgenic mice, in which 
astrocytes express enhanced GFP under the control of the mouse 
glial fibrillary acidic protein (GFAP) promoter (89, 90). TPLSM 
in vivo imaging of astrocyte Ca2+ signaling revealed abnormalities 
in astrocyte activity that may contribute to vascular instability 
and thereby to neuronal cell death in several transgenic mouse 
models of AD (91). However, whether infiltrating leukocytes 
interact with resident neural cells is completely unknown in AD 
and future studies focusing on such interactions will be necessary 
to discover and understand these new disease mechanisms.
iMAGe ACQUiSiTiON AND ANALYSiS
During image acquisition, mice are deeply anesthetized with iso-
flurane and the rate of respiration is controlled. The laser intensity 
and photomultiplier tube (PMT) gain need to be set carefully to 
minimize photodamage. The imaging volume and sampling fre-
quency must be chosen to ensure successful image analysis with 
fine resolution in time and space. Stacks of optical sections are 
serially re-acquired at defined time intervals, and cell centroids 
need to be determined in order to track cell motion. The tracks 
locate the cells at each time point. They consist of serial sets of xyz 
coordinates of single-cell centroids. The tracks are then exported 
as numerical data and are used to calculate specific parameters 
for the analysis of cell migration (36). Specialized software pack-
ages are used for automated 3D cell tracking and the analysis of 
migration paths for each cell. The automatic tracking and analysis 
of individual cells is more reliable when a small proportion of 
cells is labeled, because this reduces the likelihood of overlapping 
pixels representing different cells and allows the distinction of 
individual cells based on their centers of mass.
Several parameters can be used to analyze the migration 
behavior of cells during TPLSM experiments. Cell velocity can 
be represented as either instantaneous velocity or track velocity. 
Instantaneous velocity is a basic parameter derived from the dis-
placement of the cell divided by the elapsed time (70). The track 
velocity is calculated from the median or mean instantaneous 
FiGURe 3 | Neutrophils infiltrate the brain of 5xFAD–YFPH mice in Aβ-rich areas. Representative TPLSM images of cortical regions in 5xFAD–YFPH mice 
showing YFP neurons in green, neutrophils in red stained with cell tracker CMTPX, and Aβ plaques in blue labeled by the intravenous injection of Methoxy-X04. The 
vessel edges are traced artificially with a white line to show the vessel bed. (A) Neutrophils interact with the vascular endothelium. Scale bar = 50 μm. (B) 
Neutrophils infiltrate into the brain parenchyma, characterized by abundant Aβ plaques and weak neuronal fluorescence. Scale bar = 40 μm.
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velocity computed from all time intervals throughout a track, 
typically 6–14 time points at intervals of 20–50 s (92). Because 
leukocytes migrate along stromal cell networks, they do not travel 
along a linear path but instead make frequent turns in a “random 
walk.” Therefore, higher sampling frequencies are necessary to 
provide an accurate readout of instantaneous velocities and to 
avoid the underestimation of real velocity when cells are persistent 
for only a finite period of time (93). It is easy to find differences in 
the motility parameters of leukocytes reported in previous stud-
ies, and such differences are likely to reflect the frame rate of data 
acquisition. If there is a long gap between each frame, then the 
true velocity of the cell will be underestimated. Therefore, the “fast 
sampling” theory (the use of sampling intervals shorter than the 
persistence time of the cell) should be taken into account in order 
to correctly compare data obtained in different laboratories (93).
A useful parameter that is derived from velocity is the arrest 
coefficient, representing the fraction of time during track-
ing in which a cell does not move (threshold <  2 μm/min). It 
is calculated as the ratio of the time a cell is immotile over the 
whole observation time. The arrest coefficient is calculated from 
cell tracks and reported as the percentage of cells in the entire 
population (70). The arrest coefficient is high when leukocytes 
are in stable contact with other cells or when they swarm in a 
chemoattractant microenvironment (94).
The cell locomotion parameter allows some speculation on the 
nature of cell movement, e.g., cells may show directed migration 
along a gradient of a soluble or surface-immobilized chemoat-
tractant. The displacement of a cell moving with a constant 
velocity is the shortest distance between the positions at two time 
points (95). An accurate parameter to analyze migration patterns 
is the mean displacement (MD) plot (70), in which the average 
displacement of a population of cells over specific time intervals is 
plotted against the square root of time. The slope of the resulting 
curve can be used to determine the motility coefficient of a cell 
population and measures the volume that a cell scans per unit 
time. Cells usually exhibit directed movement for a few minutes, 
which means that during short time intervals, they tend to move 
in one preferred direction (36).
The chemotactic index, also called the meandering index 
or straightness index, is another parameter representing the 
confinement of cell tracks and is calculated based on the ratio 
of displacement from origin by track length. The meandering 
can vary between 0 (the cell returns to its exact starting position) 
and 1 (a perfectly straight cell track). Cells exhibiting frequent 
angle changes will produce tracks with low meandering indices, 
whereas a meandering index of 0.7–1 generally shows that cell 
migration has a strong directional bias (70).
During time-lapse acquisition, a moving cell is observed by 
taking snapshots at fixed time intervals; hence, the movement of 
each cell might be considered as a sequence of vectors. Trajectory 
vectors represent the direction of displacement of individual cells, 
so the calculation of angles between the direction of migration 
and various other directions in space is possible, e.g., the orienta-
tion of a blood vessel. The vector-vessel angles of individual tracks 
are useful for the description of tangential movement along an 
axis and are determined by mirroring the trajectory vectors onto 
the nearest vessel (reference vector), resulting in angles of 0–90° 
for each cell track (96).
It is important to realize that cell populations analyzed 
using the parameters described above may consist of distinct 
subpopulations that have different biological roles and migration 
behaviors. These subpopulations may be revealed by plotting 
the distribution of the parameter of interest among all cells or 
by studying correlations between multiple motility parameters. 
For example, neutrophils invading the brain parenchyma in 
AD-like mice show two distinct behaviors: the first involves a 
strong directional bias characterized by a high meandering index, 
motility coefficient, and mean track velocity, whereas the second 
is characterized by low motility and undirected movement 
resembling swarming behavior (19). The undirected motility 
behavior with numerous cells displaying full arrest indicates the 
presence of activating stop signals for neutrophils in the brains of 
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mice with AD-like pathology, whereas the directed movement of 
neutrophils strongly suggests the presence of chemotactic factors 
(19).
Other parameters calculated from leukocyte intratissue migra-
tion may reveal whether a chemoattractant released by injured 
tissue, resident cells, or recruited blood-derived leukocytes direct 
their movement. For example, after entering peripheral tissues, 
neutrophils assume an amoeboid motility profile characterized 
by coordinated migration along a chemokine gradient and cluster 
formation. The dramatic changes in neutrophil morphology 
can be analyzed by shape index (length/width), revealing the 
significant elongation of cell bodies, which is the characteristic of 
adhesion-independent movement associated with a low degree of 
cytoskeletal organization and a lack of discrete focal contacts (97).
The directional component of migration can be determined 
by measuring the turning angles of neutrophil tracks, which is 
achieved by calculating the angle change between vectors con-
structed from each time point. The peak angle distribution in 
absolute values varies in the range 0–180°, and changes of 10–30 
units indicate highly directed migration following a chemotactic 
gradient (97). In order to identify specific chemotactic molecules 
that direct leukocyte movement, instantaneous radial velocities 
can be calculated for the comparative chemotaxis analysis of 
wild-type and gene-deficient neutrophil populations (98). The 
radial velocity–time plot with fitted regression lines can provide 
insight into the recruitment dynamics of cell populations, and a 
reduction in radial velocity may be a consequence of impaired 
chemotaxis (98). Although no data are yet available in AD 
models, integrin-dependent intravascular neutrophil migration 
in sterile liver injuries requires CXCR2 ligands on liver sinusoids 
and formyl peptides in the injury zone (99). Furthermore, in 
sterile skin injuries, leukotriene B4 acts as an intercellular signal 
between neutrophils that allows rapid integrin-independent 
neutrophil recruitment throughout the tissue (98). Future studies 
are needed to characterize the dynamics of neutrophils as well as 
other leukocyte populations in the brains of AD models.
FUTURe DiReCTiONS
Two-photon laser scanning microscopy has made it possible to 
study leukocyte recruitment in the living brain, improving our 
understanding of immune cell functions in CNS diseases, such 
as AD. Advanced imaging techniques will also allow us to define 
the role of leukocyte subpopulations at different stages of disease, 
as well as the relationships among migrating leukocytes, amyloid 
deposition, and tau pathology. Moreover, it is conceivable that 
TPLSM in the AD brain will help us to visualize and analyze 
the interplay between migrating leukocytes and resident cells, 
such as microglia, neurons, and astrocytes. TPLSM could also 
be used to unravel the role of toxic molecules, such as ROS and 
NO intermediates that may be produced by invading innate 
immunity cells during AD. For example, dihydroethidium and 
hydroethidine are cell-permeable fluorescent dyes suitable for 
the evaluation of ROS synthesis in  vitro, but they have also 
been used successfully to visualize anion superoxide production 
in vivo (100, 101). The development of new fluorescent probes 
and the deep-tissue imaging capability of TPLSM may allow 
the in vivo visualization of ROS production by neural cells and 
infiltrating leukocytes.
One of the limitations of current imaging studies is the lack of 
access to deeper areas of the intact brain, such as the hippocam-
pus, which is strongly affected during AD. Nevertheless, recently 
developed micro-optics and micro-mechanical components 
have improved deep-tissue imaging (102, 103). Indeed, the use of 
micro-prisms and gradient index (GRIN) lenses allows the long-
term imaging of deep-layer cortical tissue in the mouse brain, 
although such devices must be inserted into the parenchyma, 
potentially altering neural cell functions and inducing inflam-
matory responses (102, 104). GRIN lenses feature plane optical 
surfaces and are focused by continuously changing the refractive 
index within the lens material by eliminating aberrations typically 
found in traditional spherical lenses. An alternative deep-tissue 
imaging method is stimulated emission depletion (STED) laser 
microscopy, which allows the exploration of deep areas, such as 
the hippocampus in living brains (105). This recent imaging tech-
nique improves spatial resolution by quenching the fluorescence 
everywhere except the central region, thus substantially reducing 
the size of the original fluorescence spot. Therefore, the higher 
peak signal-to-background ratio reveals more detailed structures, 
improving the quality of the images. In the near future, STED 
laser microscopy may expand to include the analysis of leukocyte 
recruitment in key brain areas during AD, leading to the identifi-
cation of new disease mechanisms. Moreover, STED technology 
brings in  vivo super-resolution microscopy to small structures 
involved in the morphofunctional interactions between astro-
cytes and neurons, suggesting future exciting opportunities for 
the study of leukocyte interactions with neural cells (106).
Overall, the augmentation of TPLSM using optical systems, 
such as GRIN lenses or STED laser microscopy, and advances 
in fluorescent dye and protein engineering to produce brighter 
and more photostable fluorophores will play an important role 
in the study of molecular mechanisms controlling leukocyte-
dependent brain injury and will help to identify new therapeutic 
approaches for AD.
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